How long should I take ceritinib/ceritinib?

Ceritinib/Ceritinib is an oral targeted drug that treats a specific type of non-small cell lung cancer (NSCLC). It is primarily used to treat NSCLC patients with ALK fusion genes. Ceritinib/The duration of use of Ceritinib will vary depending on the individual patient's circumstances and condition. For most patients, Ceritinib is a long-term maintenance drug that requires continued use to control tumor growth and spread. Usually, patients will take ceritinib orally every day under the guidance of a doctor. During treatment, doctors will regularly monitor the patient's condition and drug response, and adjust the dosage according to individual conditions. If a patient tolerates ceritinib well and shows significant efficacy, he or she may continue to use ceritinib. However, if serious adverse reactions occur or the drug is not effective, your doctor may consider other treatment options.